Immunofluorescence and flow cytometry analyses revealed NF-κB activation in tumor-infiltrating MPO+ neutrophils and a concomitant reduction of CD11b+Gr-1<sup>high</sup> neutrophils in the BM in OVA-MC38 bearing mice, suggesting therapy-driven myeloid cell egress. This evidence concerns the gene NFKB1 and neoplasm.